Adverse Effects of Low-Dose Methotrexate in a Randomized Double-Blind Placebo-Controlled Trial: Adjudicated Hematologic and Skin Cancer Outcomes in the Cardiovascular Inflammation Reduction Trial
published in: ACR Open Rheumatology
date of publication: 2020-11-17
main subject: placebo-controlled trial, skin cancer, methotrexate
Cites articles
There is nothing here
Article - wd:Q102132990